Sierra Summit Advisors’s Ambrx Biopharma Inc AMAM Stock Holding History

Sierra Summit Advisors’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-37,237	Closed	-$530K	–	229
2023 Q4	$530K	Buy	+37,237	New	+$423K	0.15%	80

Sierra Summit Advisors's AMAM Position: Q1 2024 in Review

Sierra Summit Advisors sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 37,237 shares — an estimated $530K sold.

Sierra Summit Advisors first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $530K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Sierra Summit Advisors reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Sierra Summit Advisors sold 37,237 Ambrx Biopharma Inc shares in Q1 2024, an estimated $530K.
Sierra Summit Advisors first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Sierra Summit Advisors's Ambrx Biopharma Inc position peaked at $530K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Sierra Summit Advisors's 13F filing for Q1 2024, filed 9 May 2024.